| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,012 |
2,832 |
$225K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
547 |
516 |
$66K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
261 |
248 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
492 |
464 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
728 |
698 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
534 |
512 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
26 |
24 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
143 |
130 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
140 |
68 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14 |
14 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
156 |
149 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
13 |
$1K |
| 87070 |
|
16 |
14 |
$338.72 |
| 94760 |
|
14 |
12 |
$69.39 |
| 99173 |
|
13 |
12 |
$17.71 |
| 90686 |
|
12 |
12 |
$6.00 |